We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Offers Advice on Initial Pediatric Study Plans for Cancer Drugs
FDA Offers Advice on Initial Pediatric Study Plans for Cancer Drugs
The FDA released a draft guidance for oncology drug developers on submitting initial pediatric study plans (iPSPs) after new requirements go into effect on August 18.